Global M&A deal value rose 15% year-over-year through August 2026, with megadeals above $10 billion driving the gains and pushing activity toward the second-highest annual total since 2021. Strategic buyers are prioritizing AI-related infrastructure, energy, healthcare consolidation amid patent cliffs, and cross-border opportunities amid lighter regulatory scrutiny and supportive equity markets. Trader sentiment on individual targets reflects sector momentum—higher implied probabilities attach to assets in AI, medtech, and consumer brands—while valuation gaps and integration complexity continue to limit smaller or standalone deals. Key upcoming catalysts include year-end earnings, potential FOMC signals on rates, and regulatory filings that could accelerate or stall specific transactions before the December 31, 2026 resolution.